retatrutide 2025 trial results Retatrutide: What It Is & How This New Drug Works Retatrutide Commercial Availability Timeline: Key

Non-invasive markers and imaging often guide diagnosis and monitoring

Waser, B., Beetschen, K., Pellegata, N

Because manufacturing is inconsistent, safety is not guaranteed

However, the significant weight loss it promotes can lead to a temporary condition called telogen effluvium, which is responsible for most hair thinning users report

In the event of an early discontinuation from study treatment, the early discontinuation visit included an MRI assessment if the participant had been on study treatment for at least 16 weeks

For breastfeeding moms who worry that taking semaglutide might also cause appetite suppression and weight loss for the baby, Krutsch says her research shows the drug doesn't get into breast milk